Instituto Rosenbusch S.A.

AR$138.00As of Sun 8 Nov 2026, 12:00 UTC
BCBA:ROSEHealthcare
Country Argentina
PE (Fwd) •••
TSR 10Y CAGR 33.38%
Div yield —
ROE 5.54%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.05
PE TTM 32.02
TSR TTM (14.29%)
Mkt cap AR$5.877B
ROIC (46.63%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$179
29.94%
(88.68%)
Hold 8|10|10|10|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
3.33
3.72
3.83
3.79
20.86%
30.52%
24.23%
11.59%
Revenue$M
430.5
443.8
466.6
474.9
8.76%
9.19%
9.91%
14.15%
Peers (US$3.804M)
Cap (US$)
PE
3.686M
10.78x
Capital
TTM
5Y
10Y
Leveragex
0.930
(0.729)
(0.721)
EBIT/Intx
0.909
0.267
0.336
Own earn%
(143.51)
(97.05)
(98.68)
Sh yield%
30.22
29.56
26.56
Owners
Insiders/Inst%
6.15
76.95
Short interest%
3.78
SBC / revenue%
5.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
7–12
$1 testx
—
Incr. ROIC%
1